📰 Exome Sequencing News
Exome Sequencing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exome Sequencing. Real-time updates on events, politics, business and more.
February 17, 2024
In an article published in the Journal of Pediatrics, researchers based in Brazil describe the case of a nine-year-old boy admitted to hospital with multiple symptoms and overlapping conditions that made diagnosis difficult, such as short stature, thin tooth enamel (dental enamel hypoplasia), moderate mental deficiency, speech delay, asthma, mildly altered blood sugar, and a history of recurring infections in infancy.
January 25, 2024
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The
November 15, 2023
5q-spinal muscular atrophy (5q-SMA) is one of the more common types of spinal muscular atrophy (SMA) affecting around one in ten thousand individuals worldwide.
November 13, 2023
PYC has developed a new drug candidate for the >5 million people worldwide[1] with Polycystic Kidney Disease (PKD) This drug candidate hasdemonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2] PKD is a life-changing disease affecting 1 in every 1,000 people[3] Half of the patient population withPKD will require a kidney transplant by the age of 60 due to the absence of impactful treatment options in this disease[4] PKD represents ...
October 26, 2023
Psoriasis -; a chronic skin condition -; is not caused or spread by spontaneous genetic mutations in the skin, new research suggests.
October 10, 2023
Incorporating RNA sequencing provides better diagnostics to enable a more complete understanding of disease biology...
September 15, 2023
Until quite recently, it was extremely difficult to detect the variants underlying many genetic disorders. In the absence of a defined cause, clinicians have little to guide treatment for those left without a genetic diagnosis, forcing patients and families to embark on a diagnostic odyssey with no guarantee of finding answers.
August 4, 2023
Researchers reported a proteogenomic approach to investigate fresh solid melanoma tumor material.